Patents by Inventor ShiCang YU

ShiCang YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Applications Of YD1701 In Preparation Of Drugs For Treating ALDH1A3 High-Expression Tumors
    Publication number: 20210186925
    Abstract: An application of YD1701 in preparation of a drug for treating ALDH1A3 high-expression tumor is disclosed. The YD1701 can be used as an ALDH1A3 inhibitor to reverse the occurrence of epithelial-mesenchymal transition (EMT) of ALDH1A3 high-expression cancer cells. It can reduce tumor invasion and metastasis to inhibit tumor progression and can prolong the overall survival time of tumor-bearring animals. YD1701 have low cytotoxicity.
    Type: Application
    Filed: August 21, 2018
    Publication date: June 24, 2021
    Applicant: First Affiliated Hospital Third Military Medical University Chinese People's Liberation Army P.R Of
    Inventor: ShiCang YU